mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0008 |
1 |
mRNA |
TAK-715 |
GDSC1000 |
pan-cancer |
AAC |
0.00075 |
1 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.00072 |
1 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
-0.00085 |
1 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
-0.00065 |
1 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
-0.00071 |
1 |
mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
0.00086 |
1 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
0.00056 |
1 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.00028 |
1 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00021 |
1 |